Search Results for

stroke

501-550 of 3069 Results
Sort by Relevance , Date , Title

afp20190601p670.pdf

...Administering aspirin during a heart attack or stroke can be lifesaving. The benefits of daily low-dose (81 mg) aspirin therapy to prevent recurrent cardiovascular disease (CVD) events are also well established.1 Aspirin’s routine use for primary prevention, however, has been the...

American Family Physician

https://www.aafp.org/afp/2019/0601/afp20190601p670.pdf

afp20190601p699.pdf

...STROKE Stroke is the leading cause of serious long-term disabil- ity, and most stroke survivors return home.44 These care recipients often require significant assistance with activi- ties of daily living and instrumental activities of daily liv- ing.44 A review of caregiver...

American Family Physician

https://www.aafp.org/afp/2019/0601/afp20190601p699.pdf

afp20190601p716.pdf

...two or more of the following major events: acute coronary syndrome in the past 12 months, previous myocardial infarction, previous ischemic stroke, or symp- tomatic peripheral artery disease. A patient is also very high risk if he or she has one of those major ASCVD events and...

American Family Physician

https://www.aafp.org/afp/2019/0601/afp20190601p716.pdf

afp20190601p717.pdf

...two or more of the following major events: acute coronary syndrome in the past 12 months, previous myocardial infarction, previous ischemic stroke, or symp- tomatic peripheral artery disease. A patient is also very high risk if he or she has one of those major ASCVD events and...

American Family Physician

https://www.aafp.org/afp/2019/0601/afp20190601p717.pdf

afp20190601p717a.pdf

...two or more of the following major events: acute coronary syndrome in the past 12 months, previous myocardial infarction, previous ischemic stroke, or symp- tomatic peripheral artery disease. A patient is also very high risk if he or she has one of those major ASCVD events and...

American Family Physician

https://www.aafp.org/afp/2019/0601/afp20190601p717a.pdf

afp20190601p718.pdf

...two or more of the following major events: acute coronary syndrome in the past 12 months, previous myocardial infarction, previous ischemic stroke, or symp- tomatic peripheral artery disease. A patient is also very high risk if he or she has one of those major ASCVD events and...

American Family Physician

https://www.aafp.org/afp/2019/0601/afp20190601p718.pdf

afp20190615od2.pdf

...out- comes: response or remission, cardiac-related outcomes (cardiac mortality, repeat acute coronary syndrome event, resuscitated arrest, stroke, arrhythmias, revascularization) Quality of life Cost-effectiveness Use of health care services: cardiac medication adherence,...

American Family Physician

https://www.aafp.org/afp/2019/0615/afp20190615od2.pdf

afp20190615p751.pdf

...but multiple studies have sought to clarify the optimal level of glycemic control to prevent macrovascular (e.g., myocardial infarction, stroke, death) and microvascular (e.g., retinopathy, DKD) complications of diabetes.13-15 The American Diabetes Association recommends a target...

American Family Physician

https://www.aafp.org/afp/2019/0615/afp20190615p751.pdf

afp20190701p32.pdf

...multiple treatments and modalities.22 Other conditions associated with polypharmacy in younger patients include diabetes, heart dis- ease, stroke, and cancer.24 A population often overlooked with regard to polypharmacy is patients with mental health conditions.22,25 These...

American Family Physician

https://www.aafp.org/afp/2019/0701/afp20190701p32.pdf

afp20190701p58.pdf

...is reduced with consistent physical activity. Physical activity improves function in patients with Parkinson disease, multiple sclero- sis, stroke, and other types of frailty. Cancer In addition to reductions in the risk of breast and colon cancers reported in 2008, studies have...

American Family Physician

https://www.aafp.org/afp/2019/0701/afp20190701p58.pdf

afp20190715p118.pdf

...risk. The primary outcome was a composite of nonfatal myocardial infarction, nonfatal stroke (excluding hemorrhagic stroke), vascular death, or transient ischemic attack. Transient ischemic attack was added after recruit- ment had begun, and the length of the trial was increased...

American Family Physician

https://www.aafp.org/afp/2019/0715/afp20190715p118.pdf

afp20190715p118a.pdf

...risk. The primary outcome was a composite of nonfatal myocardial infarction, nonfatal stroke (excluding hemorrhagic stroke), vascular death, or transient ischemic attack. Transient ischemic attack was added after recruit- ment had begun, and the length of the trial was increased...

American Family Physician

https://www.aafp.org/afp/2019/0715/afp20190715p118a.pdf

afp20190715p119.pdf

...risk. The primary outcome was a composite of nonfatal myocardial infarction, nonfatal stroke (excluding hemorrhagic stroke), vascular death, or transient ischemic attack. Transient ischemic attack was added after recruit- ment had begun, and the length of the trial was increased...

American Family Physician

https://www.aafp.org/afp/2019/0715/afp20190715p119.pdf

afp20190715p120.pdf

...risk. The primary outcome was a composite of nonfatal myocardial infarction, nonfatal stroke (excluding hemorrhagic stroke), vascular death, or transient ischemic attack. Transient ischemic attack was added after recruit- ment had begun, and the length of the trial was increased...

American Family Physician

https://www.aafp.org/afp/2019/0715/afp20190715p120.pdf

afp20190715p69.pdf

...in combination with aspirin to reduce the risk of major cardiovascular events (cardiovascu- lar [CV] death, myocardial infarction [MI] and stroke) in patients with chronic coronary artery disease (CAD) or peripheral artery disease. Before publication, the article was not updated to...

American Family Physician

https://www.aafp.org/afp/2019/0715/afp20190715p69.pdf

afp20190715p72.pdf

...in combination with aspirin to reduce the risk of major cardiovascular events (cardiovascu- lar [CV] death, myocardial infarction [MI] and stroke) in patients with chronic coronary artery disease (CAD) or peripheral artery disease. Before publication, the article was not updated to...

American Family Physician

https://www.aafp.org/afp/2019/0715/afp20190715p72.pdf

afp20190715p73.pdf

...in combination with aspirin to reduce the risk of major cardiovascular events (cardiovascu- lar [CV] death, myocardial infarction [MI] and stroke) in patients with chronic coronary artery disease (CAD) or peripheral artery disease. Before publication, the article was not updated to...

American Family Physician

https://www.aafp.org/afp/2019/0715/afp20190715p73.pdf

afp20190715p98.pdf

...symptoms are bilateral, fluctuating, or progressive. The evalu- ation should also include a neurologic review; history of diabetes mellitus, stroke, vasculitis, head or ear trauma, and use of ototoxic medications; and family his- tory of ear conditions and hearing loss.9-11...

American Family Physician

https://www.aafp.org/afp/2019/0715/afp20190715p98.pdf

afp20190801p184.pdf

...Dapagliflozin in High-Risk Type 2 Diabetes Reduces Hospitalization for Heart Failure But Does Not Reduce Death, Myocardial Infarction, or Stroke Clinical Question Does dapagliflozin (Farxiga) improve cardiovas- cular outcomes in patients with type 2 diabetes mellitus and...

American Family Physician

https://www.aafp.org/afp/2019/0801/afp20190801p184.pdf

afp20190801p185.pdf

...Dapagliflozin in High-Risk Type 2 Diabetes Reduces Hospitalization for Heart Failure But Does Not Reduce Death, Myocardial Infarction, or Stroke Clinical Question Does dapagliflozin (Farxiga) improve cardiovas- cular outcomes in patients with type 2 diabetes mellitus and...

American Family Physician

https://www.aafp.org/afp/2019/0801/afp20190801p185.pdf

afp20190815p208.pdf

...Asthma, Back and Neck Pain, Pain During Labor, TIA, CBT for Anxiety Is intravenous magnesium sulfate effective for the treatment of acute asthma exacerbations? Patients presenting to the emergency depart- ment with an acute asthma exacerbation that has not responded to first-line...

American Family Physician

https://www.aafp.org/afp/2019/0815/afp20190815p208.pdf

afp20190815p209.pdf

...Efficacy End Points: All-cause mortality, cardiovascular mortality, cardiovascular events, arrhythmia, stroke Harm End Points: Nausea, abdominal pain or discomfort, diarrhea, reflux, any gastrointestinal side effect, headache or worsening migraine, joint and muscle pain, skin...

American Family Physician

https://www.aafp.org/afp/2019/0815/afp20190815p209.pdf

afp20190815p249a.pdf

...Clopidogrel Plus Aspirin Prevents Second Ischemic Stroke Better Than Aspirin Alone Clinical Question Does clopidogrel (Plavix) add benefit to aspirin treatment in patients with acute minor ischemic stroke or transient ischemic attack? Bottom Line Combined treatment with...

American Family Physician

https://www.aafp.org/afp/2019/0815/afp20190815p249a.pdf

afp20190915p339.pdf

...because of stroke).40 Behavior therapies, such as assisted and timed toileting, are the primary treatment for func- tional incontinence.40 Indications for Referral Subspecialist referral should be considered for compli- cated UI to include associated pain, persistent hematuria...

American Family Physician

https://www.aafp.org/afp/2019/0915/afp20190915p339.pdf

afp20190915p369.pdf

...Clinical Commentary The current fragmentation and failure of demen- tia care are a problem of framing. Even if dementia is diagnosed correctly,1 it is viewed indiscrimi- nately, as an additional problem on the list, such as hypertension or diabetes. Prescribing acetyl-...

American Family Physician

https://www.aafp.org/afp/2019/0915/afp20190915p369.pdf

afp20190915p374.pdf

...of cancer diagnosis or the primary composite cardiovascular outcome (i.e., cardiovascular death, nonfatal myocardial infarction, or ischemic stroke). There was no dif- ference between groups regarding cardiovascular or all-cause mortality. There was a reduction in total myocardial...

American Family Physician

https://www.aafp.org/afp/2019/0915/afp20190915p374.pdf

afp20190915p375.pdf

...of cancer diagnosis or the primary composite cardiovascular outcome (i.e., cardiovascular death, nonfatal myocardial infarction, or ischemic stroke). There was no dif- ference between groups regarding cardiovascular or all-cause mortality. There was a reduction in total myocardial...

American Family Physician

https://www.aafp.org/afp/2019/0915/afp20190915p375.pdf

afp20190915p376.pdf

...of cancer diagnosis or the primary composite cardiovascular outcome (i.e., cardiovascular death, nonfatal myocardial infarction, or ischemic stroke). There was no dif- ference between groups regarding cardiovascular or all-cause mortality. There was a reduction in total myocardial...

American Family Physician

https://www.aafp.org/afp/2019/0915/afp20190915p376.pdf

afp20190915p378.pdf

...Dual Antiplatelet Therapy for High-Risk TIA and Minor Stroke: BMJ Rapid Recommendation Dual antiplatelet therapy after stroke has not previously been shown to improve outcomes over a single agent. Based on a recent randomized controlled trial followed by a systematic review,...

American Family Physician

https://www.aafp.org/afp/2019/0915/afp20190915p378.pdf

afp20191001p391.pdf

...Atherosclerosis, Hypertension, and Obesity in Young Committee of Council on Cardiovas- cular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Car- diometabolic Health. The agenda...

American Family Physician

https://www.aafp.org/afp/2019/1001/afp20191001p391.pdf

afp20191001p392.pdf

...Atherosclerosis, Hypertension, and Obesity in Young Committee of Council on Cardiovas- cular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Car- diometabolic Health. The agenda...

American Family Physician

https://www.aafp.org/afp/2019/1001/afp20191001p392.pdf

afp20191001p403.pdf

...Evidence-Based Answer Treatment of AFib with a factor Xa inhibi- tor results in a decrease in the combined end point of stroke and embolic events (odds ratio [OR] = 0.89; 95% CI, 0.82 to 0.97), as well as a decrease in intracranial hemorrhage (OR = 0.50; 95% CI, 0.42 to 0.59) and...

American Family Physician

https://www.aafp.org/afp/2019/1001/afp20191001p403.pdf

afp20191001p405.pdf

...Evidence-Based Answer Treatment of AFib with a factor Xa inhibi- tor results in a decrease in the combined end point of stroke and embolic events (odds ratio [OR] = 0.89; 95% CI, 0.82 to 0.97), as well as a decrease in intracranial hemorrhage (OR = 0.50; 95% CI, 0.42 to 0.59) and...

American Family Physician

https://www.aafp.org/afp/2019/1001/afp20191001p405.pdf

afp20191001p426.pdf

...direct oral anticoagulants are commonly used for the prevention and treatment of systemic embo- lism associated with atrial fibrillation, stroke, and venous thromboembolism (VTE). LMWH and select direct oral anticoagulants can be used for anticoagulation therapy ini- tiation on an...

American Family Physician

https://www.aafp.org/afp/2019/1001/afp20191001p426.pdf

afp20191015p462.pdf

...fibrillation beneficial for reducing the risk of stroke? A limited number of trials that examined the risk of temporary interruption of anticoagula- tion before a variety of procedures did not find a reduction in the risk of stroke, but they did show an increased risk of bleeding...

American Family Physician

https://www.aafp.org/afp/2019/1015/afp20191015p462.pdf

afp20191101od1.pdf

...heart attack, stroke Harm End Points: Major bleeding, dyspnea Narrative: Dual antiplatelet therapy (aspirin plus clopidogrel [Plavix] or ticagrelor [Brillinta]) com- pared with aspirin alone after PCI modestly reduces non- fatal events such as heart attack and stroke.1,2 This...

American Family Physician

https://www.aafp.org/afp/2019/1101/afp20191101od1.pdf

afp20191101p540.pdf

...= 100), and fewer strokes (NNT = 166) than those treated with RAS inhibitors. Patients treated with RAS inhibitors have fewer deaths and hospitalizations from heart failure than those treated with calcium channel blockers (CCBs; NNT = 83), although CCBs decrease stroke risk more...

American Family Physician

https://www.aafp.org/afp/2019/1101/afp20191101p540.pdf

afp20191101p541.pdf

...= 100), and fewer strokes (NNT = 166) than those treated with RAS inhibitors. Patients treated with RAS inhibitors have fewer deaths and hospitalizations from heart failure than those treated with calcium channel blockers (CCBs; NNT = 83), although CCBs decrease stroke risk more...

American Family Physician

https://www.aafp.org/afp/2019/1101/afp20191101p541.pdf

afp20191101p556.pdf

...from neurogenic and psychogenic stuttering. Neurogenic stuttering is an acquired form of stuttering that follows brain injury, such as from stroke or trauma. Psychogenic stuttering is a manifestation of a psychiatric condition. These forms of stuttering are much less common than...

American Family Physician

https://www.aafp.org/afp/2019/1101/afp20191101p556.pdf

afp20191115p618.pdf

...Air pollution is associated with increased risks of coronary heart disease, myocardial infarction, and stroke, and is asso- ciated with increased emergency department visits, chronic obstructive pulmonary disease and asthma exacerbations, and development of respiratory disease....

American Family Physician

https://www.aafp.org/afp/2019/1115/afp20191115p618.pdf

afp20191115p649.pdf

...within 60 minutes of pre- sentation to avoid such adverse outcomes as con- gestive heart failure, myocardial ischemia, renal failure, and stroke. CONSENSUS AND EXPERT OPINION Epidural and spinal anesthesia are appropriate options during delivery for women who have a stable...

American Family Physician

https://www.aafp.org/afp/2019/1115/afp20191115p649.pdf

afp20191201p676.pdf

...cardiovascular mortality (studied in nine trials, with varying definitions, including coronary artery disease or ischemic heart disease plus stroke) between patients undergoing general health checks and those in control groups. Further data analysis demonstrated no difference...

American Family Physician

https://www.aafp.org/afp/2019/1201/afp20191201p676.pdf

afp20191201p677.pdf

...cardiovascular mortality (studied in nine trials, with varying definitions, including coronary artery disease or ischemic heart disease plus stroke) between patients undergoing general health checks and those in control groups. Further data analysis demonstrated no difference...

American Family Physician

https://www.aafp.org/afp/2019/1201/afp20191201p677.pdf

afp20191201p680.pdf

...Multiple sclerosis, Parkinson disease, spinal cord injury, stroke, trauma Impaired mobility and/or thermoregulation Peripheral neuropathy Impaired sensation Psychiatric Alcoholism Behavioral modifications; vasodilatory effects; malnutrition/depleted glycogen stores...

American Family Physician

https://www.aafp.org/afp/2019/1201/afp20191201p680.pdf

afp20191201p687.pdf

...Functional: neurogenic bladder, diabetes, multiple sclerosis, stroke, pharmacologic adverse effects (anticholinergics, antidepressants) Prostate: benign prostatic hypertrophy, carcinoma, infection Urethral: posterior urethral valves, strictures, trauma, infections,...

American Family Physician

https://www.aafp.org/afp/2019/1201/afp20191201p687.pdf

afp20191201p709.pdf

...2007, American Family Physician pub- lished the inaugural Close-ups department, featur- ing a story about my mother, who had experienced a stroke, and my father, who cared for her at home for seven years.1 Officially, their relationship lasted 56 years, but emotionally it never...

American Family Physician

https://www.aafp.org/afp/2019/1201/afp20191201p709.pdf

afp20191215od2.pdf

...monotherapy for up to five years. The primary end point was a composite of cardiovascular death, myocardial infarction, stent thrombosis, stroke, or bleeding. Individ- uals masked to treatment group assignment adjudicated all clinical events. Complete follow-up occurred for 98.8% of...

American Family Physician

https://www.aafp.org/afp/2019/1215/afp20191215od2.pdf

afp20191215od3.pdf

...monotherapy for up to five years. The primary end point was a composite of cardiovascular death, myocardial infarction, stent thrombosis, stroke, or bleeding. Individ- uals masked to treatment group assignment adjudicated all clinical events. Complete follow-up occurred for 98.8% of...

American Family Physician

https://www.aafp.org/afp/2019/1215/afp20191215od3.pdf

afp20191215od4.pdf

...monotherapy for up to five years. The primary end point was a composite of cardiovascular death, myocardial infarction, stent thrombosis, stroke, or bleeding. Individ- uals masked to treatment group assignment adjudicated all clinical events. Complete follow-up occurred for 98.8% of...

American Family Physician

https://www.aafp.org/afp/2019/1215/afp20191215od4.pdf

afp20191215p742.pdf

...current evidence is insufficient to assess the balance of benefits and harms of statins in people older than 75 years who have no history of stroke or heart attack.2 For people 65 to 75 years of age with one or more risk factors, the U.S. Preventive Services Task Force recommends...

American Family Physician

https://www.aafp.org/afp/2019/1215/afp20191215p742.pdf

25 50 100 results per page